Oxygen is a drug. As a drug, it is unique in that humans are continuously exposed to a low, homeopathic dose from the atmosphere. Clinically, the primary indication for supplemental oxygen is to reverse hypoxemia. This drug is unique in that it is regularly delivered in unknown doses to patients without indications or attempts at titration. The casual use of oxygen by the health community may simply be secondary to the ease of application via the respiratory tract and the misnomer that too much oxygen is clearly better than too little. However, as with many medical therapies, better can be the enemy of good.
The benefit of oxygen is often conflicted with its basic yet forgotten biological harm. Severinghaus and Astrup [1] provide us with a novel and eloquent description of oxygen when they state:
''Oxygen is addicting; in its grip are all the mitochondrial-rich eukaryotes who learned to depend on it during the past 1.4 billion years. This, the first atmospheric pollutant, is the waste product of stromalites (formation of algal plankton), which excreted it at least 2.3 billion years ago. Since then sediments have been rusted or oxidized. Oxygen is toxic. It rusts a person in a century or less. With oxygen came the danger and blessing of fire. If introduced today, this gas might have difficulty getting approved by the Food and Drug Administration.''
In the intensive care unit, oxygen toxicity during mechanical ventilation is presumed to occur at levels exceeding 0.40. Oxygen is rarely a single factor to produce lung injury. Pulmonary oxygen toxicity is associated with aggressive ventilation, time, and inspired oxygen concentration (FIO 2 ) [2] [3] [4] [5] . Hyperoxia of the lung is presumed to precipitate lung injury through the production of reactive oxygen intermediates [6] . Experimental models of hyperoxic lung injury demonstrate endothelial cell injury, an increase in pulmonary capillary permeability, and a marked increase in inflammatory cells [5] .
From a clinician's perspective, the reduction of FIO 2 to safe levels through the appropriate use of positive end expiratory pressure (PEEP) and manipulation of mean airway pressure is a common and appropriate goal. The ARDSnet ARMA trial utilized a minimum FIO 2 of 0.35 and PEEP of 5 cmH 2 O. The PEEP/FIO 2 table was developed through expert opinion with knowledge that treated patients would enter the trial with a PaO 2 /FIO 2 \200 mmHg [7] . The more aggressive ARDSnet ALVEOLI trial maintained a lower FIO 2 through manipulation of PEEP, but found no differences in outcomes [8] . Historically, a higher FIO 2 limit often prevents hypoxemia during ICU manipulations and is below the threshold for pulmonary oxygen toxicity.
In this issue of Intensive Care Medicine, de Graaff and colleagues [9] demonstrate that Dutch clinicians appear to be guided by the concept of minimizing FIO 2 to levels that are presumed to be non-toxic with little regard for arterial oxygenation (PaO 2 2 or PEEP changes were made in 65-82% of cases, with higher FIO 2 resulting in the most frequent changes. These findings suggest that while there is concern about pulmonary toxicity caused by hyperoxic gas mixtures administered to the lungs, there appears to be little concern for hyperoxemia.
The 2 to create normoxemia may also mask the presence of worsening pulmonary function [10] . At a PaO 2 of 120 mmHg and oxygen saturation of 99%, a fall in PaO 2 of 50% would still provide an SaO 2 of C90%. In this instance, pulse oximetry goals would not be violated, and there would be no warning of a significant decrease in pulmonary dysfunction.
Lung injury occurs over a wide spectrum requiring individualized oxygen requirements and mechanical ventilation needs. Our recent work in closed loop control of oxygenation demonstrates that even severely injured trauma patients (injury severity score [25) can frequently be managed immediately postoperatively with an FIO 2 \0.30. In a number of cases, these patients have had PaO 2 [80 mmHg on an FIO 2 of 0.21 [11] . These data have important implications for military care in austere conditions where oxygen is a limited resource. In contrast, civilian hospitalists rarely worry if their oxygen supply will run out.
A growing body of evidence suggests that hyperoxemia may result in worse outcomes in a number of conditions. Kilgannon et al. reported results of a multi-center trial comparing outcomes in patients after non-traumatic cardiac arrest based on PaO 2 . They showed that hyperoxemia (PaO 2 C300 mmHg) was associated with increased mortality compared to both the normoxemic (PaO 2 B300 mmHg C61 mmHg) and the hypoxemic group (PaO 2 B60 mmHg) [12] . These findings support earlier animal studies of hyperoxemia following experimental cardiac arrest. In a recent systematic review of oxygen use in the treatment of myocardial infarction, Wijesinghe and colleagues [13] found few studies with significant power to evaluate the safety of oxygen therapy. However, several studies suggest that hyperoxemia may result in vasoconstriction in the coronary circulation and hemodynamic instability [14] [15] [16] [17] . These studies do not dissuade the use of oxygen following myocardial infarction, but rather reinforce the need for the titration of oxygen to a normal saturation. The concept of oxygen titration is gaining traction. Recent work with severe traumatic brain injury suggests that both hypoxemia and hyperoxemia are associated with increased mortality and disposition [18] . This is in conflict with the current trend of using hyperoxemia to achieve acceptable levels of brain tissue PO 2 when the deleterious effects of hypoxemia in this population are well described.
The work of de Graaff et al. suggests that FIO 2 titration might best be accomplished using a goal PaO 2 /FIO 2 ratio with a lower limit of FIO 2 set at 0.21. It also reminds us that, despite the fact that oxygen is ubiquitous in the hospital and easily delivered, often without a physician order, it is a drug that should be titrated to the desired effect. Both hypoxemia and hyperoxemia have consequences beyond pulmonary oxygen toxicity.
The discovery of oxygen is an interesting account of several investigators arriving at the same conclusion around 1773-1774. Before Lavoisier coined the term 'oxygen' it had been called 'nitro ariel spirits,' 'dephlogisticated air,' 'fire air,' and 'eminently breathable air' [19] . As oxygen nears its 250th birthday, it is time to treat it as an important drug with consequences for both under and over dosing. 
